Division of Eye and Vision
The Division of Eye and vision which is located at St. Erik Eye Hospital, conducts education at the undergraduate, advanced and postgraduate levels, as well as research with the aim of developing the eye care of the future.
Functional and structural analysis in relation to age at onset of Leber hereditary optic neuropathy: a Swedish cohort
In LHON, previous assessments of idebenone’s therapeutic effects have relied primarily on visual acuity outcomes, while comprehensive assessments of retinal structure and visual function, particularly in children, remain limited. In this study, we evaluated retinal structure and visual function in patients with chronic LHON to better understand long-term outcomes across different ages of disease onset. Our results showed that disease onset before 15 years of age was associated with more favorable structural and functional outcomes in the chronic stage of the disease.
Health-related quality of life and tobacco and alcohol consumption in Leber hereditary optic neuropathy in Sweden
In this study, we assessed the health-related quality of life (HRQoL), tobacco and alcohol consumption in individuals affected by Leber hereditary optic neuropathy (LHON) and asymptomatic carriers. To our knowledge, this is the first Swedish study examining HRQoL and lifestyle habits in this population.
Interestingly, HRQoL was similar among LHON affected individuals, asymptomatic carriers, and healthy controls. Smoking, snus use, and alcohol consumption were more prevalent among LHON affected individuals than among carriers and controls.
Photo: Foto: UnsplashPopular weight-loss drugs linked to rare but serious eye conditions
GLP-1 agonists such as Ozempic have changed the way clinicians manage diabetes and obesity around the world. Two new studies suggest that people taking these drugs have a small increased risk of serious eye conditions and vision loss.
Read the news article in The Conversation, written by Flora Hui and Pete Williams.
Photo: Pixabay,Mohamed HassanPete Williams awarded grant from the Swedish Brain Foundation
Each year, the Swedish Brain Foundation supports qualified research on the brain and other nervous systems, as well as diseases, injuries, and disabilities throughout the nervous system.
Pete Williams, researcher at Karolinska Institutet and St. Erik Eye Hospital, has been awarded a research grant from the Swedish Brain Foundation for his project: "NAD metabolism as a target for neuroprotection in age-related ophthalmic and neurodegenerative diseases".
The grant, which amounts to SEK 2.4 million, will fund the research over a three-year period.
Photo: Flora HuiGlaucoma researcher Pete Williams receives grant from American foundation
Pete Williams, researcher at Karolinska Institutet and St. Erik Eye Hospital, has been awarded a research grant from the American Glaucoma Foundation to develop a treatment for glaucoma and other eye diseases. With the grant of USD 75,000 (SEK 840,000), the Foundation wants to recognize groundbreaking, innovative glaucoma research. This is the second time Pete Williams has received the grant.